Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 11 12 13 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sekisui Diagnostics, LLC. (3/12/18). "Press Release: Sekisui Diagnostics Announces Asset Transfer Agreement with ImmBioMed GmbH & Co. KG". 2018-03-12
Pieris Pharmaceuticals, Inc.. (3/9/18). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update". Boston, MA. 2018-03-09
Rentschler Biopharma SE. (3/9/18). "Press Release: Rentschler Biopharma and Leukocare Demonstrate Success of Strategic Alliance for Biopharmaceutical Development and Formulation". Laupheim & Martinsried. 2018-03-09
Arsanis, Inc.. (3/9/18). "Press Release: Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017". Waltham, MA & Vienna. 2018-03-09
Evotec AG. (3/8/18). "Press Release: Evotec and Sanofi in Exclusive Talks to Create an Evotec-led Infectious Disease Open Innovation R&D Platform". Hamburg & Paris. 2018-03-08
InflaRx N.V.. (3/8/18). "Press Release: InflaRx Announces First Patient Enrolled in Phase IIb Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2018-03-08
ProBioGen AG. (3/8/18). "Press Release: ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program". Berlin. 2018-03-08
CRISPR Therapeutics AG. (3/8/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results". Zug & Cambridge, MA. 2018-03-08
Charles River Laboratories International, Inc.. (3/8/18). "Press Release: Charles River Laboratories Makes Expansions to Global Biologics Infrastructure". Wilmington, MA. 2018-03-08
Roche. (3/8/18). "Press Release: Changes to the Roche Enlarged Corporate Executive Committee". Basel. 2018-03-08
Novartis AG. (3/7/18). "Press Release: Novartis Expands Alliance with Science 37 to Advance Virtual Clinical Trials Program". Basel. 2018-03-07
Merck KGaA. (3/7/18). "Press Release: Merck Announces Positive Phase IIB Results for Evobrutinib in Relapsing Multiple Sclerosis". Darmstadt. 2018-03-07
BRAIN AG. (3/7/18). "Press Release: BRAIN, AnalytiCon Discovery and Roquette Reach Major Milestone in DOLCE Program for Natural- based Sugar and Calorie Reduction in Food and Beverages Faster than Originally Expected". Zwingenberg, Potsdam & La Madeleine 2018-03-07
Selexis S.A.. (3/7/18). "Press Release: Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics". Geneva. 2018-03-07
Celgene Corporation. (3/6/18). "Press Release: Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ. 2018-03-06
Curetis N.V.. (3/6/18). "Press Release: Curetis Subsidiary Ares Genetics Wins Incubator Stay in Silicon Valley". Amsterdam & San Diego, CA & Holzgerlingen. 2018-03-06
Novartis AG. (3/6/18). "Press Release: Novartis' Xolair Recommended in New Global Chronic Urticaria Guideline". Basel. 2018-03-06
BRAIN AG. (3/6/18). "Press Release: BRAIN AG Establishes US Subsidiary to Strengthen Business Development in North America". Zwingenberg. 2018-03-06
Eurofins Scientific. (3/6/18). "Press Release: Eurofins Exceeds Its Recently-upgraded 2017 Objectives on a Strong Growth Momentum and Raises Its Objectives for 2018". 2018-03-06
BIA Separations d.o.o.. (3/5/18). "Press Release: BIA Separations and Nuvonis Technologies Partner to Support Vaccine and Gene Therapy Production". Ajdovšcina & Vienna. 2018-03-05
Heidelberg Pharma AG. (3/5/18). "Press Release: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive MultiTarget Research Agreement for the Development of Antibody Drug Conjugates". Ladenburg & Cambridge, MA. 2018-03-05
G1 Therapeutics, Inc.. (3/5/18). "Press Release: G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer". Research Triangle Park, NC. 2018-03-05
Addex Therapeutics S.A.. (3/5/18). "Press Release: Addex Secures Investor Commitment for CHF40 Million Capital Increase Following Successful Completion of Book Building Process". Geneva. 2018-03-05
ViraTherapeutics GmbH. (3/5/18). "Press Release: ViraTherapeutics Starts Second Oncolytic Virus Development Program with Boehringer Ingelheim". Innsbruck. 2018-03-05
Business France. (3/2/18). "Press Release: Biotechnology and Laboratory Technology from France at Analytica". 2018-03-02
Heidelberg Pharma AG. (3/1/18). "Press Release: Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center". Ladenburg. 2018-03-01
Affiris AG. (3/1/18). "Press Release: Affiris Announces Results of a Phase I Clinical Study Using Affitopes PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients". Vienna. 2018-03-01
Bruker Corporation. (3/1/18). "Press Release: Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation". Billerica, MA. 2018-03-01
Basilea Pharmaceutica Ltd.. (3/1/18). "Press Release: Basilea Names Adesh Kaul as New Member of its Management Committee". Basel. 2018-03-01
Enzymicals AG. (3/1/18). "Press Release: Signed Cooperation Agreement. Special Chemical Manufacturers abcr GmbH and Enzymicals AG Want to Make Use of Synergies". Greifswald & Karlsruhe. 2018-03-01
Rentschler Biopharma SE. (2/28/18). "Press Release: Rentschler Biopharma SE Appoints Federico Pollano as Senior Vice President, Business Development". Laupheim. 2018-02-28
BRAIN AG. (2/28/18). "Press Release: BRAIN AG Starts the Financial Year 2017/18 with a Weak First Quarter". Zwingenberg. 2018-02-28
ERS Genomics Ltd.. (2/28/18). "Press Release: European Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications". Dublin. 2018-02-28
German Accelerator Life Sciences. (2/28/18). "Press Release: German Accelerator Life Sciences Appoints Vice President Germany". Berlin & Cambridge, MA. 2018-02-28
Thermo Fisher Scientific Inc.. (2/28/18). "Press Release: Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea". Waltham, MA. 2018-02-28
Novo Holdings A/S. (2/27/18). "Press Release: Novo Holdings Launches USD 165m Impact Fund to Combat Antimicrobial Resistance". Copenhagen. 2018-02-27
Basilea Pharmaceutica Ltd.. (2/27/18). "Press Release: Basilea Reports Significantly Improved Financial Results in 2017". Basel. 2018-02-27
Hume Brophy. (2/27/18). "Press Release: Hume Brophy International Healthcare Launches New Life Sciences Division". London. 2018-02-27
Selexis S.A.. (2/26/18). "Press Release: Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates". Geneva. 2018-02-26
Valneva S.E.. (2/26/18). "Press Release: Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate against Zika Virus". Gaithersburg, MD & Lyon. 2018-02-26
Bruker Corporation. (2/26/18). "Press Release: Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon". Orlando, FL. 2018-02-26
Berlin Cures Holding AG. (2/26/18). "Press Release: Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study". Zug & Berlin. 2018-02-26
Miltenyi Biotec GmbH. (2/26/18). "Press Release: MolMed and Miltenyi Biotec. EMA Approves the Utilization of the CliniMACS Prodigy Equipment". Milan & Bergisch Gladbach. 2018-02-26
AiCuris Anti-infective Cures GmbH. (2/23/18). "Press Release: AiCuris’ Licensee MSD Launches Prevymis (letermovir) in Germany". Wuppertal. 2018-02-23
Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel. 2018-02-23
BCNP Consultants GmbH. (2/23/18). "Press Release: More than 1,200 Meetings at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-02-23
Qiagen N.V.. (2/23/18). "Press Release: Qiagen Opens Shared Services Center in Taguig City, Manila". Manila. 2018-02-23
Streck, Inc.. (2/23/18). "Press Release: Streck, Inc. Files Suit against Cenata GmbH for Infringement of Its European Patent". La Vista, NE. 2018-02-23
BRAIN AG. (2/22/18). "Press Release: BRAIN AG Expands Patent Protection for Unique Taste Cell Technology to Europe". 2018-02-22
Bruker Corporation. (2/22/18). "Press Release: Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM²". Ettlingen. 2018-02-22
Medigene AG. (2/21/18). "Press Release: Medigene Receives Approvals for Its First Clinical Trial with TCR Therapy MDG1011". Planegg. 2018-02-21
Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel. 2018-02-21
Bruker Corporation. (2/21/18). "Press Release: Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer". Billerica, MA. 2018-02-21
G1 Therapeutics, Inc.. (2/21/18). "Press Release: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights". Research Triangle Park, NC. 2018-02-21
Cullinan Oncology, LLC. (2/20/18). "Press Release: Cullinan Oncology and MAB Discovery Announce Collaboration to Develop Novel Antibody-Based Therapeutics". Cambridge, MA & Neuried. 2018-02-20
Bruker Corporation. (2/20/18). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. 2018-02-20
Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. 2018-02-20
Siemens AG. (2/19/18). "Press Release: Siemens Plans IPO of Siemens Healthineers AG in the First Half of Calendar Year 2018 [Not for United States, Australia, Canada or Japan]". Erlangen & Munich. 2018-02-19
Avillion LLP. (2/16/18). "Press Release: Avillion Advances Co-development Programme with Merck. IND Now Open for Phase 2 Study of M1095, an anti-IL-17 A/F Nanobody in Psoriasis". London. 2018-02-16
Pieris Pharmaceuticals, Inc.. (2/16/18). "Press Release: Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares". Boston, MA. 2018-02-16
Affimed N.V.. (2/15/18). "Press Release: Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. 2018-02-15
Addex Therapeutics S.A.. (2/15/18). "Press Release: Addex Launches CHF40 million Capital Increase with Commitments from Specialist US Healthcare Investors". Geneva. 2018-02-15
Roche. (2/15/18). "Press Release: Roche to Acquire Flatiron Health to Accelerate Industry-wide Development and Delivery of Breakthrough Medicines for Patients with Cancer". Basel. 2018-02-15
Merck KGaA. (2/15/18). "Press Release: Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer [Not intended for UK-based media]". Darmstadt. 2018-02-15
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. 2018-02-15
Cell Medica Ltd.. (2/15/18). "Press Release: Cell Medica Announces the Appointment of Kevin Boyle as Chief Financial Officer". 2018-02-15
Bruker Corporation. (2/14/18). "Press Release: The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology". Billerica, MA. 2018-02-14
Recipharm AB. (2/14/18). "Press Release: Recipharm Appoints President Development Services to Drive End to End Offering". 2018-02-14
Affimed N.V.. (2/13/18). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. 2018-02-13
Gilde Healthcare Partners. (2/13/18). "Press Release: Gilde Healthcare Company RAD-x Continues Buy & Build with Acquisition of Swiss Medical Imaging Centers". Utrecht. 2018-02-13
Sciomics GmbH. (2/12/18). "Press Release: Sciomics Participates in Collaborative Clinical Trials for the Treatment of Metaphyseal Chondrodysplasia Type Schmid (MCDS)". Heidelberg. 2018-02-12
Affimed N.V.. (2/12/18). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. 2018-02-12
Lonza Group AG. (2/12/18). "Press Release: Lonza Expands Cell-Culture Portfolio with Quasi Vivo System". Basel. 2018-02-12
Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA. 2018-02-09
Boehringer Ingelheim. (2/9/18). "Press Release: Boehringer Ingelheim Refocuses PDE9 Inhibition Brain Research on Schizophrenia Following Results from Phase II Alzheimer’s Trials". Ingelheim. 2018-02-09
Bruker Corporation. (2/8/18). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results". Billerica, MA. 2018-02-08
Fluidigm Corporation. (2/8/18). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress". South San Francisco, CA. 2018-02-08
Genedata AG. (2/8/18). "Press Release: Genedata Bioprocess Licensed to Pfizer Inc.". Basel. 2018-02-08
Lonza Group Ltd.. (2/8/18). "Press Release: Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines". Basel & South San Francisco, CA. 2018-02-08
University of Bayreuth. (2/8/18). "Press Release: Innovative Research Infrastructure with a Global Reputation. The Northern Bavarian NRM Centre Repositions Itself". 2018-02-08
c-LEcta GmbH. (2/8/18). "Press Release: c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company". 2018-02-08
Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. 2018-02-07
Addex Therapeutics S.A.. (2/7/18). "Press Release: Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management". Geneva. 2018-02-07
Analytik Jena AG. (2/7/18). "Press Release: Laboratory Automation Solution Designed to Boost Productivity Showcased at SLAS 2018". San Diego, CA & Jena. 2018-02-07
Lonza Group Ltd.. (2/7/18). "Press Release: Lonza Partners with Prolog Ventures to Establish VC Fund to Invest in Consumer Health and Wellness Startups". Basel. 2018-02-07
Sanofi S.A.. (2/7/18). "Press Release: Sanofi Delivers 2017 Business EPS(1) in Line with Guidance". Paris. 2018-02-07
ProBioGen AG. (2/7/18). "Press Release: ProBioGen and Teva Sign License Agreement on Human Artificial Lymph Node Technology". Berlin. 2018-02-07
ImmunoQure AG. (2/6/18). "Press Release: Servier and ImmunoQure AG Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody". Paris & Düsseldorf. 2018-02-06
Genedata AG. (2/6/18). "Press Release: Genedata Announces New Solution for NGS-Based Biosafety Assessment". Basel. 2018-02-06
Idorsia Ltd.. (2/6/18). "Press Release: Idorsia Announces Financial Results for 2017 – Company Off to a Great Start – 4 Compounds to Enter Phase 3 Development". Allschwil. 2018-02-06
InflaRx N.V.. (2/6/18). "Press Release: InflaRx Announces Appointment of Tony Gibney to Its Board of Directors". Jena. 2018-02-06
Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków. 2018-02-06
Sophia Genetics S.A.. (2/6/18). "Press Release: Sophia Genetics Announces CE-IVD Marking of Its Genomic Test for Leukemia Detection". Lausanne. 2018-02-06
Faron Pharmaceuticals Oy. (2/5/18). "Press Release: Faron Establishes Second Traumakine Manufacturing Site". Turku. 2018-02-05
Addex Therapeutics S.A.. (2/5/18). "Press Release: Addex Provides Key Financial Indicators and Trading Update. Cash Position of CHF6.5 million as of 31 January 2018". Geneva. 2018-02-05
SGS S.A.. (2/2/18). "Press Release: SGS Acquires TraitGenetics GmbH, Germany". 2018-02-02
Genedata AG. (2/2/18). "Press Release: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer". Basel. 2018-02-02
4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-02-01
Medigene AG. (2/1/18). "Press Release: Medigene Strengthens Its Patent Portfolio with a US Patent on a Tagged TCR". Planegg. 2018-02-01
Lab Automation Network (LAN). (2/1/18). "Press Release: Cytosurge AG and Lab Automation Network Announce Partnership for Automated Single-cell Biology Applications". 2018-02-01
next pagenext page 1 2 3 ... 11 12 13 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top